Creation of a Biological Collection of BRonchiaI and Pulmonary Tissues From Surgical wastE

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age1-80
SponsorUniversity Hospital, Bordeaux

About this trial

The biological samples and associated data will facilitate the successful implementation of the research collaboration between Bordeaux University Hospital and the University of Bordeaux on the pathophysiology of bronchopulmonary diseases. In the longer term, this research could lead to the discovery of new therapeutic targets for asthma, chronic obstructive pulmonary disease (COPD), pulmonary hypertension, and acute respiratory distress syndrome.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Male or female

Adult or children

Having required or necessitating, in the context of care or research involving the human person promoted by the Bordeaux University Hospital (ARISE, BIRDIES, ICEBERG, VIRCHILLD) or by Inserm (COBRA), either thoracic surgery such as lobectomy, pneumonectomy or lung transplantation in the Thoracic Surgery Department of the Haut Lévêque Hospital, or bronchial fiberscopy with biopsies and/or bronchial brushing and/or BAL at the children's hospital of the Pellegrin Hospital or at the Haut Lévêque Hospital.

Having received or, for children whose holders of parental authority have received, an information note with the possibility of opposition in accordance with the MR004 (French law - Commission Nationale de l'Informatique et des Libertés (CNIL))

Disqualifiers

Patient or holder of parental authority for children who have expressed their opposition to participation in the research

Trial population

The population includes male and female participants of all ages (adults and children) who are undergoing or require specific thoracic or bronchial procedures, sputum, nasal brushing, blood as part of clinical care or research. These procedures are conducted under the auspices of Bordeaux University Hospital (e.g., ARISE, BIRDIES, ICEBERG, VIRCHILLD) or Inserm (e.g., COBRA).

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Fiberscopic samples

    Procedure/Surgery

    Perform brushing and/or bronchial biopsies and/or BAL and/or aspiration during bronchial fiberscopy and surgical waste during a lobectomy.

  • Sputum

    Procedure/Surgery

    Sputum has been collected for biological analysis.

  • Nasal brushing

    Procedure/Surgery

    Nasal brushing is a minimally invasive medical procedure used to collect cellular samples from the nasal lining by gently rubbing a small cytology brush against the mucosa.

  • blood sampling

    Procedure/Surgery

    Blood sampling is the safe collection of a blood specimen from a vein, finger, or artery to run medical lab tests

Treatment groups

650 Participants
are divided into 3 treatment groups
Group A: Patient with COPD3 interventions
Group B: Patient with Asthma4 interventions
Group C: Healthy volunteer1 intervention

Trial outcomes

Primary outcomes

1

Describe tobacco consumption

Number pack in years

Time frame
At enrollment
2

Describe tobacco statut

Described as either non-smokers, former smokers or current smokers

Time frame
At enrollment
3

Description of demographic status

Gender (male or female)

Time frame
At enrollment
4

Description of demographic status

Age as years

Time frame
At enrollment

Secondary outcomes

1

Mesure of blood gas parameter

PaO2: arterial pressure in oxygen,

Time frame
At enrollment
2

Mesure of blood gas parameter

PaCO2: arterial pressure in carbon dioxide

Time frame
At enrollment
3

Mesure of blood gas parameter

pH

Time frame
At enrollment

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: